Holliston-based Harvard Bioscience has reportedly fallen out of compliance with the Nasdaq stock exchange. The move reportedly followed the resignation of board member Alan Edrick earlier this month on June 10, which leaves the biotech company with only two board members and Nasdaq requires three. The Worcester Business Journal reports Harvard Bioscience is actively seeking a new board member to get back in compliance which they have to do by either their next annual stockholders meeting or June 10, 2026.
